Co-Diagnostics (CODX) Reports FY Loss of $1.20

Co-Diagnostics (NASDAQ: CODX) reported FY EPS of ($1.20). Revenue for the period came in at $6.8 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15